Johnson & JohnsonVarmennettu tili

@JNJNews

At Johnson & Johnson, we blend heart, science and ingenuity to profoundly change the trajectory of health for humanity. Follow us to learn more and connect.

Liittynyt helmikuu 2009

Twiitit

Olet estänyt käyttäjän @JNJNews

Haluatko varmasti nähdä nämä twiitit? Twiittien näyttäminen ei poista käyttäjän @JNJNews estoa.

  1. Kiinnitetty twiitti
    18. lokak.

    As the world’s largest healthcare company, is committed to building a future where everyone can thrive in their own . How are we working to achieve this goal? Watch to learn about our commitment to solving some of the toughest health challenges around the globe.

    Kumoa
  2. 22 tuntia sitten

    Recognized for our excellence in manufacturing innovation, has been awarded two new Lighthouse designations from the 's Global Lighthouse Network, bringing our total to seven designations—more than any other company. See how our values help create a healthier world.

    Kumoa
  3. 19. marrask.

    Hear more from J&J leaders and their goals for advancing healthcare and health equity.

    Näytä tämä ketju
    Kumoa
  4. 19. marrask.

    is strengthening its pipeline of diverse talent as part of its . LaMont Bryant, Worldwide Vice President, Regulatory Affairs at Ethicon, Inc., Johnson & Johnson Medical Devices, shares the importance of having diverse voices.

    Näytä tämä ketju
    Kumoa
  5. 18. marrask.

    ., Vice Chairman of the Executive Committee, , discusses the future of healthcare at .

    Kumoa
  6. 18. marrask.

    Joe Wolk, Executive Vice President, Chief Financial Officer, , discusses the progress we've shared at .

    Kumoa
  7. 18. marrask.

    Jennifer Taubert, EVP, Worldwide Chairman, Pharmaceuticals, , shares how ’s focus on transformational medicine is helping advance the next wave of innovation at .

    Kumoa
  8. uudelleentwiittasi
    18. marrask.

    During a Q&A discussion, Vanessa Broadhurst outlined our plans to launch novel gene and cell therapies around the world.

    Kumoa
  9. 18. marrask.

    Mathai Mammen, M.D., Ph.D., Global Head of R&D, , discusses how the company's robust pipeline will help deliver meaningful impact to patients around the world at .

    Kumoa
  10. 18. marrask.

    Alex Gorsky, Chairman & CEO, , reflects on ’s progress at .

    Kumoa
  11. 18. marrask.

    The 2021 Pharmaceutical Business Review is now LIVE. Join us as leaders discuss the company’s progress and what they envision for the future:

    Kumoa
  12. uudelleentwiittasi
    17. marrask.

    Najat Khan discusses how our differentiating expertise in Data Science & Digital Health are helping to accelerate time to diagnosis, match patients to targeted therapies, generate real-world evidence, ensure diversity and inclusion in our trials and more.

    Kumoa
  13. 17. marrask.

    Learn more about ’s bold commitment to help eradicate racial and social injustice as a public health threat.

    Näytä tämä ketju
    Kumoa
  14. 17. marrask.

    Today, the Johnson Hall Clock Tower is lit red in honor of the one year announcement anniversary. This symbol serves as a reminder of the role employees play in creating health equity and how we live into Our Credo values.

    Näytä tämä ketju
    Kumoa
  15. 17. marrask.

    With cutting-edge therapies and personalized approaches, is helping improve outcomes for cancer patients. Peter Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology, , shares how these efforts ladder up to our ultimate goal to eliminate cancer.

    Kumoa
  16. 17. marrask.

    James List, M.D., Ph.D., Global Therapeutic Area Head, Cardiovascular, Metabolism and Retina, , shares progress in our ability to help treat cardiovascular disease and diseases of the liver, kidney and retina.

    Kumoa
  17. 16. marrask.

    Join Johnson & Johnson and on Thursday, November 18 for the 2021 Pharmaceutical Business Review, where leaders will share exciting progress on our key therapeutic areas, data science and more. Register now:

    Kumoa
  18. uudelleentwiittasi
    15. marrask.

    Congratulations to Macaya Douoguih, M.D., M.P.H. on being recognized as one of 2021’s Fiercest Women in Life Sciences by for her tireless work in vaccine research and development. Read more:

    Kumoa
  19. 15. marrask.

    Helping a patient see their kids graduate. Developing new therapies so doctors can provide personalized care. These moments are what drive 's Dr. Jeff Infante to develop transformational cancer treatments so everyone, everywhere can thrive in their own .

    Kumoa
  20. uudelleentwiittasi
    6. marrask.

    The 2021 has been awarded to Katalin Karikó, PhD & Drew Weissman, MD, PhD, who enabled the use of in the development of COVID-19 vaccines. Join the virtual Award Symposium on 11/19

    Kumoa
  21. 12. marrask.

    Johnson & Johnson announces plans to accelerate innovation, serve patients and consumers and unlock value through intent to separate consumer health business. Learn More

    Kumoa

Lataaminen näyttää kestävän hetken.

Twitter saattaa olla ruuhkautunut tai ongelma on muuten hetkellinen. Yritä uudelleen tai käy Twitterin tilasivulla saadaksesi lisätietoja.

    Saatat pitää myös

    ·